生命科学资讯

Would You Still Hold Thermo Fisher Scientific Stock If It Fell Another 30%? - Trefis

Lonza To Establish Global Capability Centre In Hyderabad - BW Healthcare World

Lonza GCC Hyderabad: Swiss pharma giant to set up global capability centre - Deccan Herald

FDA official questions need for advisory committees

Senior FDA official refutes uniQure's claims amid controversy over Huntington's gene therapy

Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal

Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug

Thermo Fisher Scientific (NYSE:TMO) CEO Sells $2,562,000.00 in Stock - MarketBeat

Swiss CDMO giant Lonza group to set up GCC in Hyd - The Times of India

Thermo Fisher Scientific (TMO) Valuation Check After Recent Share Price Pullback - simplywall.st

Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug - Fierce Biotech

Kura says its menin inhibitor is preferred treatment for some payers

Roche partner Zealand posts Phase 2 data for amylin obesity drug

Roche, Element and Ultima push toward the $100 genome

Efficient amyloid-β degradation in Alzheimer’s disease using SPYTACs

Genetically encoded fluorescent reporters to visualize α-synuclein pathology in live brain

Restoring circadian rhythms in the hypothalamic paraventricular nucleus reverses aging biomarkers and extends lifespan in male mice

Tenaya, Alnylam ink research collab to find gene targets for cardio drugs

Pressure builds as back-and-forth between uniQure and FDA intensifies

Alltrna undergoes third layoff round before entering clinic, cutting 35% of jobs